Harold Mastalerz

机构：Bristol-Myers Squibb (United States)

发表论文 67 篇 · 总被引 1018 次 · h-index 18

代表论文

• Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers: Inhibition of Aggregation by Methoxytriethyleneglycol Chains (2002 · Journal of Medicinal Chemistry · 被引 139)
• Discovery of a 2,4-Disubstituted Pyrrolo[1,2-f][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development (2009 · Journal of Medicinal Chemistry · 被引 94)
• Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling (2006 · Clinical Cancer Research · 被引 79)
• Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages (2002 · Bioorganic & Medicinal Chemistry Letters · 被引 50)
• The discovery of BMS-275183: an orally efficacious novel taxane (2003 · Bioorganic & Medicinal Chemistry · 被引 48)
• New dual inhibitors of EGFR and HER2 protein tyrosine kinases (2005 · Bioorganic & Medicinal Chemistry Letters · 被引 44)